Skip to main content

TBPH

Theravance Biopharma, Inc.

Company with tickers: TBPH

CIK
1583107
CUSIP
G8807B106
Shares Outstanding
51,553,005
13F Activity (30d)
12 filings 9 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 171
Total Value: $812,182,898
Total Shares: 50,042,084
Showing 1–100 of 177 holdings by value · page 1 of 2

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 171 13F filers
Top Holder
19.0%
Sep 2023 → Mar 2026 · range 14.7% – 21.2%
of institutional value
Top 5
57.7%
Sep 2023 → Mar 2026 · range 56.5% – 62.8%
of institutional value
Top 10
71.2%
Sep 2023 → Mar 2026 · range 70.3% – 80.1%
of institutional value
HHI
841
Sep 2023 → Mar 2026 · range 830 – 1,016
Broadly held

Quarterly Activity

vs Mar 23, 2026
New
170
Increased
0
Decreased
0
Sold Out
0
Unchanged
1
Holder count: +170
Institutional value: +638.4%
Shares held: +571.1%

Top New Positions

vs Mar 23, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 23, 2026
No fully closed positions this quarter.
Showing 100 of 177
Export CSV
Holder Value (USD) % of 13F Shares Open